Biogen and AbbVie retracts ZINBRYTA for relapsing multiple sclerosis
Biogen and Abbvie asserted voluntary worldwide withdrawal of ZINBRYTA for relapsing multiple sclerosis. Taking into account the limited number of patients who are being treated,…
Read More...
Read More...
